drugset / Trial / NCT00467454

Naltrexone in the Treatment of Pyromania

NCT00467454

Phase 2 Withdrawn University of Minnesota
RandomizedSingle-groupDouble-blindTreatment

Summary

The proposed study will consist of 8 weeks of treatment with either naltrexone or placebo in 10 subjects with pyromania.

Timeline

Start
2007-06
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naltrexone Small molecule

Indications